Cover Image

Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A

Giorgio L Colombo1,2, Sergio Di Matteo2, Maria Elisa Mancuso3, Elena Santagostino31University of Pavia, School of Pharmacy, Pavia, Italy; 2S.A.V.E. Studi Analisi Valutazioni Economiche, Milan, Italy; 3Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda, Ospeda...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maria Elisa Mancuso (Author), Sergio Di Matteo (Author), Giorgio L Colombo (Author), et al (Author)
Format:	Book
Published:	Dove Medical Press, 2011-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
by: Giorgio L Colombo, et al.
Published: (2009)

Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran
by: Rasekh HR, et al.
Published: (2011)

Effects of coagulation factor concentrate prophylaxis in moderate and severe hemophilia A patients at a single hemophilia center in Korea
by: Byung Suk Moon, et al.
Published: (2013)

Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis
by: V Nicosia, et al.
Published: (2008)

Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II
by: Enrico Torre, et al.
Published: (2020)

Utility of hemophilia joint health score in a children not on prophylaxis a cross-sectional study
by: Anand Prakash
Published: (2022)

Cost–Utility Analysis of Transcatheter Aortic Valve Implantation versus Surgery in High-Risk Severe Aortic Stenosis Patients in Thailand
by: Permsuwan U, et al.
Published: (2022)

Functional evaluation of joint in moderate to severe hemophilia patients treated with on-demand factor replacement: insights from a single hemophilia treatment center in Bangladesh
by: Sujan Ghosh, et al.
Published: (2024)

Modeling of Body Weight Metrics for Effective and Cost-Efficient Conventional Factor VIII Dosing in Hemophilia A Prophylaxis
by: Alanna McEneny-King, et al.
Published: (2017)

Emicizumab prophylaxis for people with hemophilia A: Waste estimation and the Brazilian perspective
by: Ricardo Mesquita Camelo, et al.
Published: (2023)

Short-term intermittent prophylaxis post-intracranial hemorrhage in children with hemophilia
by: Novie Amelia Chozie, et al.
Published: (2022)

Damoctocog Alfa Pegol for Hemophilia A Prophylaxis: An Italian Multicenter Survey
by: Ezio Zanon
Published: (2023)

Real pandemic world results of pharmacokinetic-tailored personalized prophylaxis of bleeds in Polish children and adolescents with severe hemophilia A
by: Tomasz Urasiński, et al.
Published: (2023)

Initial experience of Emicizumab prophylaxis in children with inhibitor positive severe hemophilia A from a single center in India
by: Nita Radhakrishnan, et al.
Published: (2021)

GlycoPEGylated recombinant factor IX for hemophilia B in context
by: Santagostino E, et al.
Published: (2018)

Fc-fusion technology and recombinant FVIII and FIX in the management of the hemophilias
by: Mancuso ME, et al.
Published: (2014)

Cost–consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context
by: Schinco P, et al.
Published: (2014)

The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein–Barr virus disease
by: Heather E Vezina, et al.
Published: (2009)

Advantages of palatal cystotomy, demanded for treating cystic structures in the patient with inhibitors hemophilia A
Published: (2020)

Cost-Utility of Antimicrobial Prophylaxis for Treatment of Children With Vesicoureteral Reflux
by: Nader Shaikh, et al.
Published: (2020)

Medical costs and hospital utilization for hemophilia A and B urban inpatients in China: a national cross-sectional study
by: Zhengwei Huang, et al.
Published: (2022)

Managing Severe Hemophilia A in Children: Pharmacotherapeutic Options
by: Regling K, et al.
Published: (2022)

Hemophilia
Published: (2012)

Real-world experience of emicizumab prophylaxis in young children with hemophilia A: retrospective data from China
by: Guoqing Liu, et al.
Published: (2022)

Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation
by: Colombo GL, et al.
Published: (2012)

Management of Pregnancy in a Patient with Severe Hemophilia Type A
by: Vipra Sharma, et al.
Published: (2013)

NONSPECIFIC ULCERATIVE COLITIS AND SEVERE HEMOPHILIA A COMBINATION IN CHILDREN
by: E.I. Alieva, et al.
Published: (2010)

NONSPECIFIC ULCERATIVE COLITIS AND SEVERE HEMOPHILIA A COMBINATION IN CHILDREN
by: E.I. Alieva, et al.
Published: (2010)

Aggressive Neuroblastoma in a Pediatric Patient with Severe Hemophilia A
by: Lidia Costa, et al.
Published: (2021)

Cost analysis of hemophilia treatment in a Brazilian public blood center
by: Adriana Aparecida Ferreira, et al.
Published: (2020)

Cost-effectiveness of gene therapy for persons with severe hemophilia A and B (PWSH) in seven low- and middle-income countries (LMICS)
by: Nita Radhakrishnan, et al.
Published: (2024)

Budget Impact Analysis of the use of emicizumab for bleeding prophylaxis in patients with Hemophilia A with inhibitors in the Brazilian Health System
by: Nicolas Segre, et al.
Published: (2022)

A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy
by: Giorgio L Colombo, et al.
Published: (2011)

Hemophilia Recent Advances
Published: (2019)

Knowledge about hemophilia among teachers of patients with hemophilia in Indonesia
by: Max Frans Jozef Mantik, et al.
Published: (2020)

Monkeypox and hemophilia
by: Rujittika Mungmunpuntipantip, et al.
Published: (2023)

Clot waveform analysis to differentiate mild, moderate, and severe hemophilia A
by: Ina Susianti Timan, et al.
Published: (2024)

Effects of Treatment Model on Bone Metabolism in Patients with Severe Hemophilia A
by: Şefika Akyol, et al.
Published: (2024)

Neonatal hemophilia: a rare presentation
by: Nuno Ferreira, et al.
Published: (2015)

Pharmacokinetic variability of factor VIII concentrates in Chinese pediatric patients with moderate or severe hemophilia A
by: Zhenping Chen, et al.
Published: (2021)